These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29129987)

  • 21. Patterns of amphotericin B killing kinetics against seven Candida species.
    Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii.
    Batista-Duharte A; Lastre M; Romeu B; Portuondo DL; Téllez-Martínez D; Manente FA; Pérez O; Carlos IZ
    Int Immunopharmacol; 2016 Nov; 40():277-287. PubMed ID: 27639705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies on cell stimulatory, permeabilizing and toxic effects induced in sensitive and multidrug resistant fungal strains by amphotericin B (AMB) and N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Szlinder-Richert J; Cybulska B; Grzybowska J; Borowski E; Prasad R
    Acta Biochim Pol; 2000; 47(1):133-40. PubMed ID: 10961686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of amphotericin B activity against Candida albicans by superoxide radical.
    Okamoto Y; Aoki S; Mataga I
    Mycopathologia; 2004 Jul; 158(1):9-15. PubMed ID: 15487314
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Kong Y; Wang Q; Cao F; Zhang X; Fang Z; Shi P; Wang H; Shen Y; Huang Z
    Free Radic Res; 2020 Apr; 54(4):231-243. PubMed ID: 32295440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The MAPK Hog1 mediates the response to amphotericin B in Candida albicans.
    Guirao-Abad JP; Sánchez-Fresneda R; Román E; Pla J; Argüelles JC; Alonso-Monge R
    Fungal Genet Biol; 2020 Mar; 136():103302. PubMed ID: 31756382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous nitric oxide accumulation is involved in the antifungal activity of Shikonin against Candida albicans.
    Liao Z; Yan Y; Dong H; Zhu Z; Jiang Y; Cao Y
    Emerg Microbes Infect; 2016 Aug; 5(8):e88. PubMed ID: 27530748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of amphotericin B on the metabolic profiles of Candida albicans.
    Cao Y; Zhu Z; Chen X; Yao X; Zhao L; Wang H; Yan L; Wu H; Chai Y; Jiang Y
    J Proteome Res; 2013 Jun; 12(6):2921-32. PubMed ID: 23672250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualization analysis of the vacuole-targeting fungicidal activity of amphotericin B against the parent strain and an ergosterol-less mutant of Saccharomyces cerevisiae.
    Kang CK; Yamada K; Usuki Y; Ogita A; Fujita KI; Tanaka T
    Microbiology (Reading); 2013 May; 159(Pt 5):939-947. PubMed ID: 23475946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of amphotericin B and its low toxic derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester, with fungal, mammalian and bacterial cells measured by the energy transfer method.
    Szlinder-Richert J; Cybulska B; Grzybowska J; Bolard J; Borowski E
    Farmaco; 2004 Apr; 59(4):289-96. PubMed ID: 15081346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Insights Regarding Yeast Survival following Exposure to Liposomal Amphotericin B.
    Teixeira-Santos R; Ricardo E; Guerreiro SG; Costa-de-Oliveira S; Rodrigues AG; Pina-Vaz C
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6181-7. PubMed ID: 26248358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
    Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new look at the antibiotic amphotericin B effect on Candida albicans plasma membrane permeability and cell viability functions.
    Chudzik B; Koselski M; Czuryło A; Trębacz K; Gagoś M
    Eur Biophys J; 2015 Feb; 44(1-2):77-90. PubMed ID: 25557523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungicidal drugs induce a common oxidative-damage cellular death pathway.
    Belenky P; Camacho D; Collins JJ
    Cell Rep; 2013 Feb; 3(2):350-8. PubMed ID: 23416050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B.
    Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP
    J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro amphotericin B susceptibility of korean bloodstream yeast isolates assessed by the CLSI broth microdilution method, Etest, and Minimum fungicidal concentration test].
    Park JY; Shin JH; Uh Y; Kim EC; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Korean J Lab Med; 2008 Oct; 28(5):346-52. PubMed ID: 18971615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.